Company / Operating Income per Share
AGIOS PHARMACEUTICALS, INC. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$8.26
FY2025
5-year range
-$8.26 / -$6.18
FY2021-FY2025
Trend
-8.5%
vs FY2024
Sector context
#191 of 201
Health Care
What the data says
Among 201 Health Care companies, AGIOS PHARMACEUTICALS, INC. is in the bottom 5% for operating income per share. Operating Income per Share has declined for 3 consecutive years, from $-6.18 in FY2022 to $-8.26 in FY2025.
Based on SEC 10-K filings.
-8.26 in FY2025.
Declined from $-7.11 to $-8.26 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 201This company -$8.26 Sector average -$3.23
▼
-155.5% below sector average
Key checks
Key Insights
- AGIOS PHARMACEUTICALS, INC.'s operating income per share has declined for 3 consecutive years.
- In FY2025, operating income per share decreased 8.5% year-over-year.
- Ranks #191 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$8.26 | -8.5% |
| FY2024 | -$7.61 | -7.0% |
| FY2023 | -$7.11 | -15.0% |
| FY2022 | -$6.18 | +1.2% |
| FY2021 | -$6.26 | -18.1% |
| FY2020 | -$5.30 | +2.5% |
| FY2019 | -$5.43 | -32.0% |
| FY2018 | -$4.12 | +45.8% |
| FY2017 | -$7.60 | -42.5% |
| FY2016 | -$5.33 | -408.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026